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genomic data. Finally, I outline several areas that need further methodological
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Abstract
Mapping genes for complex human diseases is a challenging problem due to the fact that many
such diseases are due to both genetic and environmental risk factors and many also exhibit phe-
notypic heterogeneity, such as variable age of onset. Information on variable age of disease onset
is often a good indicator for disease heterogeneity and incorporation of such information together
with environmental risk factors into genetic analysis should lead to more powerful tests for ge-
netic analysis. Due to the problem of censoring, survival analysis methods have proved to be very
useful for genetic analysis. In this paper, I review some recent methodological developments on
integrating modern survival analysis methods and human genetics in order to rigorously incorpo-
rate both age of onset and environmental covariates data into aggregation analysis, segregation
analysis, linkage analysis, association analysis and gene risk characterization. I also briefly dis-
cuss the issue of ascertainment correction and survival analysis methods for high-dimensional
genomic data. Finally, I outline several areas that need further methodological developments.
1 Introduction
The major burden of ill health in western society, and to a growing extent in developing societies,
is due to complex chronic diseases such as coronary heart disease, stroke, breast cancer, prostate
cancer, and diabetes. It is believed that both genetic and environmental factors contribute to
both the risk of developing many of these common human diseases and also the responses to
treatments. Because multiple genetic and environmental factors may play important roles in the
susceptibility of individuals to develop these diseases and in the variation in treatment responses
they are often referred to as complex traits. While the data necessary to study different complex
traits are trait specific, the underlying principles and statistical methods of analysis of the genetic
component are applicable to a variety of traits.
One important feature of many complex human diseases is disease heterogeneity due to genetic
and other etiological factors. For example, many complex diseases exhibit variability in age of
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onset, and early age of onset has been a hallmark for genetic predisposition in many diseases that
aggregate in families. Therefore, age of onset outcomes such as age at diagnosis, are frequently
gathered in genetic and epidemiological studies, including both genetic association and linkage
studies. An important feature of age of onset data is the censorship resulting from being too
young to develop the disease or death before developing the disease. This makes it possible for
some of the unaffected siblings to share the disease gene with the affected siblings, who might be
too young to exhibit the trait. In fact, affected relatives with different ages of onset may also be
the result of different genetic etiologies. Age of onset data have been used to distinguish between
two sub-forms of breast cancer (Claus et al., 1990; Hall et al., 1990) and prostate cancer (Carter
et al., 1992). For these adult onset cancers, carriers of high-risk alleles were estimated to have
an earlier onset of cancer than noncarriers (sporadic cases). Taking into account age of onset
information has been shown to be important in studying disease correlation and aggregation (Li
et al., 1998; Li and Thompson, 1997), in parametric linkage analysis (Morton and Kidd, 1980;
Haynes et al., 1986), in segregation analysis (Li and Thompson, 1997; Li et al., 1998), and in
allele-sharing based linkage analysis (Li and Zhong, 2002; Zhong and Li, 2004; Li et al., 2002).
A study by Li and Hsu (2000) also indicates that ignoring age of onset can reduce the power of
both the allele-sharing-based linkage test and the transmission/disequilibrium test (TDT).
Another important feature of many complex traits is that many of these traits are known or
suspected to be influenced by various environmental risk factors and interactions between genetic
and environmental risk factors (G x E), e.g., breast cancer (Andrieu and Demenais, 1997) and
rheumatoid arthritis (Brennan et al., 1996). From a statistical standpoint, ignoring existing
gene-environment interactions can result in underestimation of both genetic and environmental
effects (Ottman, 1990), in incorrect conclusions with regard to the mode of inheritance and
the magnitude of genetic effects in segregation analysis (Tiret et al., 1993), and lower power in
detecting genetic linkage (Towne et al., 1997; Guo 2000a, 2000b).
Information on variable age of disease onset is often a good indicator for disease heterogene-
ity and incorporation of such information together with environmental risk factors into genetic
analysis should lead to more powerful tests for genetic analysis. Due to the problem of cen-
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soring, survival analysis methods, which are particularly developed for handling censoring, have
proved to be very useful for genetic analysis. In this paper, I review some recent methodological
developments in genetic epidemiology in order to rigorously take into account age of onset and
environmental risk factors in aggregation analysis, segregation analysis, linkage and family-based
association analysis and in gene risk characterization in the population. I also briefly discuss the
issue of ascertainment correction and survival analysis methods for high-dimensional genomic
data. Although I attempt a full and balanced treatment of most available literature, naturally
the presentation leans in parts towards my own work. At the end of this review, I outline several
areas that I think need further methodological developments, in particular, in the areas when
high-throughput genomic data such as the genome-wide single nucleotide polymorphisms (SNPs)
data are available.
2 Survival Analysis Methods for Aggregation Analysis
The purpose of aggregation analysis is to test whether disease aggregates within a family after
some known environmental risk factors are taken into account. The ideal design is to collect
a random sample of N families from the study population and to collect both age of disease
onset/age at censoring data and the environmental risk factors of all the individuals within the
families sampled. Then test of disease aggregation within family is equivalent to testing whether
ages of onset of family members are correlated after adjusting for environmental risk factors.
I first define some notations that are used throughout this review. Suppose we have a col-
lection of N families collected randomly or by some ascertainment criteria. Let the subscript ik
indicate the ith individual in kth family, i = 1, · · · ,mk, k = 1, · · · , N . Tik is the age at onset, Cik
the censoring age, tik=min(Tik, Cik), and δik = I(tik = Tik), where I(.) is the indicator function.
The observed data are (tik, δik, Xik), where Xik is a p-dimensional vector of covariates that are
independent of the genotype.
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2.1 Shared frailty models based on random sample of families
The most commonly used model for assessing disease aggregation is the shared frailty model,
which assumes the following conditional hazard function,
λik(t|Zk) = λ0(t) exp(Xikβ)Zk, (1)
where λ0(t) is the baseline hazard function, Xik is the individual-specific covariate vector, β is
the corresponding risk ratio parameters, and Zk is the family-specific random effect or shared
frailty. If Z1, · · · , Zk, · · · , ZN are assumed to be i.i.d from a gamma distribution Γ(ν, η), where ν
is the shape parameter and η is the scale parameter, the model is also called the gamma frailty
model, Clayton or Clayton-Oakes model (Clayton, 1978; Oakes, 1982). For identifiability of
λ0(t), it is assumed that ν = η so that E(Z) = 1. Estimation of such a model has been a subject
of active research since the mid-eighties (Clayton and Cuzick, 1985; Self and Prentice, 1986;
Klein, 1991; McGilchrist, 1993; Murphy, 1994; Nielsen et al., 1992; Glidden and Self, 1999). The
most common nonparametric maximum likelihood estimates (NPMLE) of the parameters can be
obtained by the EM algorithm. Other assumptions on the frailty distribution include positive
stable distribution (Hougaard, 1995) and log-normal distribution. Different distributions induce
difference dependency structures of the age of onset within family. Glidden (1999) provides a
model checking procedure for the gamma frailty model.
Under the shared frailty model (1), the null hypothesis of no disease aggregation can be
formulated as testing
H0 : var(Z) = ν = 0.
For randomly sampled families, the standard inference procedure for the shared frailty model is
based on the EM algorithm and likelihood ration test for H0 (Klein, 1991; Nielsen et al., 1992).
The theoretical development was given by Murphy (1994) for the shared gamma frailty models.
2.2 Multivariate frailty models
The limitation of the shared frailty model for investigating disease aggregation within a family is
that such a model assumes the same degree of dependency for any pairs of individuals within a
4
Hosted by The Berkeley Electronic Press
family, which is likely to be violated when disease aggregation is due to genetic segregation within
the families. One way of extending the shared frailty model is to assume an individual specific
additive frailty. For example, Peterson (1998) defined the following additive frailty model,
λik(t|ηk) = λ0(t) exp(Xikβ)Zik, (2)
Zik = Zk0 + Zi, (3)
where Zik is the individual-specific frailty, the frailty Zk0 is the shared frailty by family members
in the kth family and is assumed to follow a Γ(ν0, η), Zi are the individual specific frailties and
assumed to follow Γ(ν1, η). For the purpose of identifiability of λ0(t), it is often assumed that
ν1 + ν0 = η so that E(Z) = 1. Under this additive gamma frailty model (2), the null hypothesis
of interest is
H0 : ν0 = 0.
Peterson (1998) presented an EM algorithm to obtain the NPMLE for the parameters and Parner
(1998) developed the asymptotic theorem for the estimators and likelihood ratio test for H0.
If the main goal is to test for disease aggregation due to genetic segregation, one should
explicitly model the family dependence. Extensions of the frailty models to account for kinship
relationship have been developed in recent years. One approach by Korsgaard and Andersen
(1998) is in the framework of additive gamma frailty models, where the additive individual-
specific frailties are explicitly defined based on gene segregation. Another approach is to assume
that the log of the family-specific frailty vector log(Zk) = {log(Z1k), · · · , log(Znkk)} follows a
multivariate normal distribution MVN(0,Σ), where the variance-covariance matrix is defined
by the kinship coefficient matrix. Estimation of such multivariate normal frailty models includes
the Monte Carlo or approximate EM algorithm (Palmgren and Ripatti, 2002) or the penalized
partial likelihood approach (Ripatti and Palmgren, 2000).
2.3 Familiar aggregation based on case-control family design
As an alternative to family cohort design for assessing disease aggregation, the case-control sam-
pling design is often used for rare diseases because a sufficient number of cases can be ascertained.
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In family studies, investigators use the case-control design to enroll relatives for more detailed
information, obtain medical records to validate reported disease, and obtain biospecimens for
studies of genetic markers associated with the disease. Case-control family studies allow a direct
examination of the disease outcomes in relatives and collection of both risk factor and expo-
sure data on each individual, and with measured genetic markers, permits a more complete
assessment of genetic and environmental factors through segregation and linkage analysis. Such
a case-control study identifies a sample of diseased cases, and for each case, an independent
sample of age-matched disease-free controls. For each identified individual (the proband), his
environmental covariates, his family structure, and the disease status, age of onset (or age at
censoring) and environmental covariates of his relatives are obtained.
When analyzing such case-control family data, one has to account for both the sampling issue
and also the dependency of age of onset within the family. Estimating the marginal hazard func-
tion from the correlated failure time data arising from casecontrol family studies is complicated
by non-cohort study design and risk heterogeneity due to unmeasured, shared risk factors among
the family members. By assuming a Clayton multivariate survival model, Li et al. (1999) de-
veloped a procedure based on Prentice and Breslow’s (1976) retrospective likelihood formulation
assuming a parametric baseline hazard function. The method provides a way to combine the
information relating disease incidence to risk factors in relatives with the information contained
in the case-control contrasts in order to obtain more precise estimates of the effects of the puta-
tive risk factors. Shih and Chatterjee (2001) developed a similar estimation procedure but leave
the baseline hazard function unspecified. Hsu et al. (2004) proposed a two-stage estimation
procedure. At the first stage, we estimate the dependence parameter in the distribution for the
risk heterogeneity without obtaining the marginal distribution first or simultaneously. Assuming
that the dependence parameter is known, at the second stage we estimate the marginal hazard
function by iterating between estimation of the risk heterogeneity (frailty) for each family and
maximization of the partial likelihood function with an offset to account for the risk heterogeneity.
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3 Survival Analysis Methods for Segregation Analysis
The goal of genetic segregation analysis is to develop a genetic model that best describes the
disease aggregation within a family. Often it is assumed that a major gene with/without poly-
genes is involved in disease segregation. Segregation analysis based on parametric distributional
assumptions on age of onset distribution is simple; instead, I review two semiparametric models
developed for segregation analysis.
3.1 The Cox-Gene model for gene segregation
Assuming that a single major Mendelian diallelic locus governs the age-specific disease rate and
the corresponding alleles are a and A, where A is the dominant disease allele with allele frequency
P (A) = q, let gik be the genotype of ikth individual, taking one of three values aa,Aa, or AA. Li
and Thompson (1998) developed the following Cox-Gene model. They assume that conditional
on the unobserved major genotypes gik, ages of onset are assumed to be independent with a
hazard function for the ikth individual:
λik(t|Xik, gik) = λ0(t)exp(β′Xik + µik) (4)
where
µik =
 0 if gik = aaµ if gik = Aa or AA
under the assumption of a dominant mode of inheritance. The vector parameter β specifies the
log of the risk ratios associated with the covariates, and λ0(t) is an unspecified baseline hazard
function. Let Λ0(t) =
∫ t
0
λ(s)ds be the cumulative hazard function. Since A is the disease allele,
we assume that µ ≥ 0. Li and Thompson (1998) further developed a Monte Carlo EM algorithm
for estimating the parameters, especially for large pedigrees when the exact computation of the
EM algorithm is not feasible.
Similar models were also developed and studied by Gauderman and Thomas (1994) and
Siegmund and McKnight (1999). Chang et al. (2005) established the asymptotic properties
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of the NPMLE from the EM algorithm. Chang et al. (2006) developed a faster algorithm for
computing the NPMLE than the EM algorithm.
3.2 Cox model with major gene and random environmental effects
for age of onset
The Cox-Gene model (4) assumes that the disease aggregation is due to segregation of one major
gene, which accounts for all the correlation among the family members. To account for possible
shared environmental effects, Li et al. (1997) defined a model to allow for both major gene
effects and shared environmental effects by introducing a family-specific gamma random effect.
Specifically, conditional on individual-specific major genotype gik and family-specific random
environment k, ages of onset are independent with the hazard function for the ik
th individual:
λik(t|Xik, gik, k) = λ0(t)k exp(β′Xik + µgik), (5)
where µgik = 0 if gik = aa or µ if gik = Aa or AA, is the genetic effect. The vector parameter β




λ(s)ds is the cumulative hazard function. The family effect, k, is assumed
to be i.i.d. gamma variate with mean 1 and unknown variance ν. This model incorporates
the dependencies due to gene segregation and to shared environment. It is appropriate only
for data on many families; variance ν is estimable only with a set of at least 3 families. The
full model is specified by Θ = (µ, q, θ, β,Λ0(t)). If θ = 0, k = 1.0 with probability 1 for all
families, and model (5) reduces to the Cox-Gene model (4). If µ = 0 or q = 0, model (5)
reduces to the gamma frailty model. The parameters associated with the frailties are {µ, q, θ}.
The genetic effects are measured by two parameters q and µ, where q measures the frequency
of genetic susceptibility and µ measures the extent of genetic effects. The family-specific effects
are measured by parameter ν; a larger value of ν corresponds to a stronger familial dependence
due to common environmental effects and greater heterogeneity between families. Mendelian
dependence of µgik makes it possible in theory to separate the genetic effects from the shared
environmental effects and thus to identify and estimate the model parameters.
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Li et al. (1997) developed an MCEM algorithm for estimating the model parameters and
applied this model to analysis of a breast cancer family data set. The null hypothesis of interest
includes H0 : ν = 0; when rejected, it implies that the major gene segregation cannot explain
all the correlation of disease risks within families and additional genes or shared environmental
factors may exist.
4 Survival Analysis Methods for Linkage Analysis
Linkage analysis examines the co-segregation of disease locus and markers or genomic loci within
a family. Model-based linkage analysis often assumes a penetrance function and a specific mode
of inheritance and tests whether the recombination fraction between the candidate disease locus
and the marker locus is 0.5. Model-free allele-sharing-based linkage analysis is based on test-
ing whether the probability distribution of identity-by-descent (IBD) among affected sib pairs
deviates from the null probability or whether the distribution of the inheritance vector at a pu-
tative disease locus deviates from the null distribution under Mendelian segregation among the
affected relatives (Kruglyak et al., 1996). Incorporating age of onset or covariate data into para-
metric model-based linkage analysis is easy, simply by introducing age-dependent and covariate-
dependent penetrance functions. In the following, I only review the survival analysis methods
for allele-sharing-based linkage analysis based on the inheritance vectors.
4.1 Construction of genetic frailties for sibship
In order to adequately model the within-family dependency of age of onset variable to segregation
of genes, the genetic frailties should be defined according to the law of Mendelian segregation.
Li (2002) gave the following construction of the genetic frailties based on the concept of inheri-
tance vectors (Kruglyak et al., 1996; Lander and Green, 1987). Consider a sibship with n sibs,
1, 2, · · · , n, and denote their parents as F for the father andM for the mother. Assuming that the
father and mother are unrelated, there are only four unique alleles that are distinct by descent at
a given locus. Consider the setting of Kruglyak et al. (1996), where we have a series of markers
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on a chromosomal region that may harbor the disease-causing locus/loci. Suppose d is a point in
this test chromosomal region. We are interested in testing whether there is a disease-susceptible
(DS) gene linked to locus d. Arbitrarily label the paternal chromosomes containing the locus of
interest by (1,2), and label the maternal chromosomes by (3,4). The inheritance vector (Kruglyak
et al., 1996; Lander and Green, 1987) of a sibship at the d locus is the vector
Vd = (v1, v2, · · · , v2j−1, v2j, · · · , v2n−1, v2n),
where v2j−1 = 1 or 2, v2j = 3 or 4 for j = 1, 2, · · · , n. The inheritance vector indicates which
parts of the genome at locus d are transmitted to the n children from the father and the mother.
Li and Zhong (2004) define the additive genetic frailties due to the gene linked to locus d for
the father and mother as
ZdF = Ud1 + Ud2,
ZdM = Ud3 + Ud4,
where Ud1 and Ud2 are used to represent the genetic frailties due to part of the genome on the
two chromosomes of the father at locus d; Ud3 and Ud4 are analogous though for the mother. For
a given inheritance vector vd at the d locus for a sibship, we define the frailty for the jth sib as
Zdj = Udv2j−1 + Udv2j
for j = 1, 2, · · · , n. This definition is based on the fact that it is the parts of the genome of the
parents that are transmitted to the sibs, and the inheritance vectors indicate which parts are
transmitted. We further assume that the Ud1, Ud2, Ud3 and Ud4 are independently and identically
distributed across different families as Γ(νd/2, η), where the parameter η is the inverse scale
parameter, and νd is the shape parameter. Then Zdj is distributed as Γ(νd, η), for j = 1, 2, · · · , n.
Taking into account possible genetic contributions to the disease not due to the single disease
locus linked to d, e.g., due to loci unlinked to locus d, or contributions to shared familial effects,
we add another random frailty term, Up, to the genetic frailty, and define the genetic frailty for
the jth sib as
Zj = Zdj + Up
10
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= Udv2j−1 + Udv2j + Up.
We assume that Up is distributed as Γ(νp, η) over different sibships. Then Zj follows a Γ(νd+νp, η)
distribution. It is easy to verify that both the conditional (on Vd) and the marginal means of the
frailties are
E(Z1) = E(Z2) = · · · = E(Zn) = νd + νp
η
,
and both the conditional and the marginal variances of the frailties are
V ar(Z1) = V ar(Z2) = · · · = V ar(Zn) = νd + νp
η2
.
So the parameter νd can be interpreted as the proportion of the variance of the genetic frailty
that can be explained by the gene linked to the locus d.
The frailties for a sibship can be written into a matrix form as
Z = HU, (6)
where
Z = {Z1, Z2, · · · , Zn}′,
H =

a11 a12 a13 a14 1
...
an1 an2 an3 an4 1
 ,
U = {Ud1, Ud2, Ud3, Ud4, Up}′ ,
where aj1 = I(v2j−1 = 1), aj2 = I(v2j−1 = 2), aj3 = I(v2j = 3), aj4 = I(v2j = 4) for j =
1, 2, · · · , n, where I(.) is the indicator function.
4.2 The additive genetic gamma frailty model for sibship data
Consider a sibship with n sibs. Let Tj be the random variable of age at disease onset for the
jth sib. Let (tj, δj) be the observed data where tj is the observed age at onset if δj = 1, and
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age at censoring if δj = 0. We assume that the hazard function of developing disease for the jth
individual at age tj is modeled by the proportional hazards model with random effect Zj,
λj(tj|Zj) = λ0(t) exp(X ′jβ)Zj, for j = 1, 2, · · · , n, (7)
where λ0(t) is the unspecified baseline hazard function, Xj is a vector of observed covariates for
the jth sib, and β is a vector of regression parameters associated with the covariates. Zj is the un-
observed genetic frailty constructed by equation (6) in the previous section. Since Z1, Z2, · · · , Zn
are dependent due to gene segregation and shared frailty, T1, T2. · · · , Tn are therefore depen-
dent. Finally, to make the baseline hazard λ0(t) identifiable, we let νd + νp = η, which sets
E(Zj) = 1, j = 1, 2, · · · , n, and prevents arbitrary scaling in model (7). Under this restriction,
there are two free parameters, νd and νp, and Zdj ∼ Γ(νd, νd+νp), and Zp ∼ Γ(νp, νd+νp). We may
also consider reparameterization in terms of the two frailty variances, σd = V ar(Udj) = νd/η
2,
and σp = V ar(Up) = νp/η
2. Let σdp = σd + σp denote the variance of Zj. We then have
Zdj ∼ Γ(σdσ−2dp , σ−1dp ), and Zp ∼ Γ(σpσ−2dp , σ−1dp ).
Based on this additive genetic gamma frailty model, Li and Zhong (2004) derived the joint
survival function of age of onset data within a family as a function of the baseline hazard function,
the covariate effects and the parameters related to the frailty. In addition, the null hypothesis
that the disease locus is not linked to the candidate locus d can be reformulated as
H0 : νa = 0,
which is equivalent to assuming that the additive variance due to the gene linked to locus d is zero.
In order to test this hypothesis, an estimate of the baseline hazard function is often required.
However, the data collected for linkage analysis such as affected sib pairs or affected relatives
do not often provide enough information for estimating such population-level baseline hazard
functions. Instead, Li and Zhong (2004) developed a retrospective likelihood ration test for this
null hypothesis assuming that the baseline hazard function can be estimated from external data
such as the SEER database for various types of cancers.
Zhong and Li (2004) further extended the additive genetic gamma frailty model to simultane-
ously consider linkage to two unlinked loci and demonstrated that simultaneously searching for
12
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two loci can result in increased power to detect linkage when the disease risk is affected by two un-
linked genes. Instead of assuming gamma frailty models, one can also assume a log-multivariate
normal frailty where the variance-covariance matrix is specified by kinship coefficients and pair-
wise IBD-sharing proportions (Pankratz et al., 2005). Further, Pankratz et al. (2005) proposed a
procedure using Laplace approximation for estimating model parameters and for testing linkage,
i.e., testing whether the additive variance due to a given locus is zero.
5 Survival Analysis Methods for Family-based Genetic
Association Analysis
Association studies look for specific alleles at a marker locus that are more frequent in affected in-
dividuals (cases) than in the unaffected population (controls). Population-based studies compare
allele frequencies in cases and controls, but this methodology has been criticized as prone to false
positives due to population admixture. To eliminate the effect of disequilibrium created by pop-
ulation stratification, and therefore to eliminate the false positive mapping results, family-based
association methods such as haplotype relative risk (Falk and Rubinstein, 1987), the transmis-
sion disequilibrium test (TDT) (Spielman and Ewens, 1995; Spielman and Ewens, 1996), and
a likelihood-based method (Schaid, 1996; Schaid and Li, 1997) using affected and family-based
controls are often used. Li and Hsu (2001) demonstrated the importance of incorporating age of
onset data into family-based genetic association analysis.
5.1 Survival analysis methods for family-based association tests
There are several approaches that extend the TDT to handle age of onset or age at censoring. Li
and Fan (2000) proposed a linkage disequilibrium-based Cox (LDCox) model for nuclear family
data and used a robust Wald’s test for association. Mokliatchouk et al. (2001) and Shih and
Whittemore (2002) developed likelihood-based score statistics to test for association between
a disease and a genetic marker. The score statistic can be written as a weighted sum over
family members of their observed minus expected genotypes. Age of onset data can be used
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in the weight, which is the difference between the observed and expected value, δi − Λ0(ti) for
individual i, where Λ0(ti) is the cumulative hazard function at age ti, which is assumed to be
known from external data sources. Both methods of Li and Fan (2002) and Shih and Whittemore
(2002) assume that the genetic effects on the risk of onset are proportional in the framework of
the Cox regression model. Jiang et al. (2006) developed a family-based association test for time-
to-onset data assuming time-dependent differences between the hazard functions among different
genotype groups by using the weighted logrank approach of Flemming and Harrington (1981).
5.2 Test of genetic association in the presence of linkage
It is well known that genetic linkage induces within family association of phenotypes such as
disease onset or age at disease onset. A limitation of most family-based association tests is that,
although they remain valid tests of linkage, they are not valid tests of association if related nuclear
families and or sibships from larger pedigrees are used. The allele-sharing-based linkage analysis
only considers allele sharing by descent pattern among the sibs within a sibship. However, it
does not differentiate which allele they share as long as they share it by descent. In other words,
linkage analysis does not consider which particular allele is shared by the sibs. On the other
hand, the association that we are interested in is the association due to LD. For association
analysis and LD analysis, the particular allele that an individual carries determines his/her risk
of developing disease, since different marker alleles have different coupling frequencies with the
disease variant if LD exists. In typical tests of association, it is very rare that the genetic marker
itself is the disease susceptible locus (DSL). When the marker locus is not the DSL but is in
LD with it, all sibling resemblance or lack of resemblance and within sibship correlation of age
of onset cannot be fully accounted for by the genotypes at the marker locus. Motivated by this
key difference between linkage and LD, Zhong and Li (2004) defined a joint model for the risk
of disease to account for both the allele sharing information and the genotype information at
the candidate marker locus by including the genetic frailties derived from the inheritance vector.
Specifically, consider a candidate marker d in the linked region and let g = (g1, · · · , gn) denote
the vector of genotypes at marker locus d of the n sibs of known age at onset or censoring. Zhong
14
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and Li (2004) assume that the hazard function of developing disease for the jth individual at
age tj is modeled by the proportional hazards model with random effect Zj,
λj(tj|Zj) = λ0(tj) exp(Xgjβ)Zj, for j = 1, 2, · · · , n, (8)
where λ0(t) is the unspecified baseline hazard function and Xgj denotes some function of the jth
offspring’s marker genotype in the family. For example, for additive model, Xgj = l, l = 0, 1, 2,
counts the number of the putative high-risk marker allele and corresponds to the genotype of
jth member in the family who carries l copies of the putative high-risk marker allele. Zj is the
unobserved genetic frailty, which is defined as in equation (6).
When β = 0, the hazard function (8) and the joint survival function for a sibship do not
depend on the genotype at the marker locus d; therefore, tests of allelic association between
locus d and the disease or the null hypothesis that the genotype at the marker locus is not
associated with the risk of the disease can be formulated as testing
H0 : β = 0.
Zhong and Li (2004) developed a score test for H0 based on a retrospective likelihood function,
which is a weighted sum over family members of their observed minus expected genotypes, where
weights depend on both age of onset and also the IBD sharing between the sibs within a family.
Different from score tests for linkage and association, the score test for testing association in the
presence of linkage is also a function of allele-sharing IBD among the sib pairs or the inheritance
distribution among the sibships. Zhong and Li (2004) demonstrated by simulations that such a
score test indeed results in correct a type 1 error rate when testing for association in the linked
region.
6 Survival Models for Haplotype Effects Based on Co-
hort, Case-Cohort and Nested Case-Control Designs
The most commonly used design for population-based haplotype analysis is the case-control
design. Although case-control studies can potentially identify disease-predisposing variants, such
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studies have certain limitations. This includes the tendency for clinically diagnosed cases to
represent more severe ends of the whole disease spectrum and difficulty in selecting unbiased
controls. In addition, such designs may suffer recall bias in disease status and other covariates
such as family history (Doll, 1964; Collins, 2004). In contrast, large-scale population -based
cohort studies can overcome these limitations. The prospective population cohorts can also enable
the studies of many complex diseases in the same cohort. Large cohort studies are designed to
learn about gene and environmental effects for relatively rare diseases. However, since many of
the environmental covariates of interest are expensive to obtain, to reduce the cost of large cohort
studies, several alternative sampling schemes within the framework of cohort studies have been
suggested and well-studied and widely applied in the traditional epidemiological investigations.
Among these, the most popular ones are the case-cohort design proposed by Prentice (1986) and
the nested case-control design proposed by Thomas (1977) and Liddell et al. (1977). I review
some recent methods for haplotype association analysis for cohort data, case-cohort data and
nested case-control data. In order to account for variable age of onset, survival analysis methods
are required for testing the haplotype effects for cohort, case-cohort and nested case-control
designs.
6.1 Survival model for haplotype inference based on cohort data
Assume that N individuals are collected from a cohort and are type over K SNP markers.
Consider the proportional hazards model to relate the disease risk to haplotype. Specifically, for
the ith individual in the cohort, we assume the following Cox proportional hazards model
λ(ti|Xi, Hi) = λ0(ti) exp(β ′F(Xi, Hi)) (9)
to relate the hazard function to the covariates vector Xi and the haplotype Hi, where F(Xi, Hi)
is a known function to parameterize the covariates and the haplotype. Here the haplotype Hi
can be over a set of SNPs in a candidate gene or SNPs in a sliding window in the whole-genome
study. Depending on the model we choose, there are many different ways to parameterize the
function F(Xi, Hi). For example, if h0 is a particular haplotype of interest, we can assume the
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following multiplicative model with haplotype and covariate interaction,
F(Xi, Hi) = β1(I(hl = h0) + I(hm = h0)) + β2Xi + β3Xi(I(hl = h0) + I(hm = h0)),
where (hl, hm) are the pair of the haplotype of Hi.
Lin (2004) proposed a likelihood-based approach and EM algorithm for estimating the param-
eter β and for haplotype inference for the proportional hazards model (9) in full cohort studies
of unrelated individuals. Chen et al. (2004) derived a score test based on the partial likelihood
function for testing the null hypothesis H0 : β = 0, which is much easier to implement than the
likelihood-based approach of Lin (2004). However, although the method of Lin provides estimate
of the haplotype risk ratio parameters and the baseline hazard function, the method may suffer
computational instability due to possible many rare haplotypes.
6.2 Test of haplotype association for case-cohort and nested case-
control designs
Liddell et al. (1977) and Thomas (1977) suggested an alternative design called nested case-
control design, in which a cohort is followed to identify cases of some disease of interest and then
controls are selected for each case from within the cohort (i.e., controls are a random sample of
unaffected individuals from the risk set in the cohort at the event time). Cases and controls can
be matched on some covariates. In a such design, the covariates of interest are only measured
for the cases and controls. For nested case-control data, Chen et al. (2004) developed a score
test for H0 : β = 0 in model (9). Alternatively, if the disease onset information is available for
the full cohort, one can develop an EM algorithm for obtaining the NPMLE for the parameters
associated with the model (9). An alternative design to the nested case-control design is the
case-cohort design, as proposed by Prentice (1986) for large survey studies such as the Women’s
Health Study, where the population size makes it infeasible to collect data on all of the individuals
in the cohort. If there is a concurrent registry that can be used to identify all of the subjects
who experience an event, then it is possible to collect covariates data on only a sub-cohort of the
subjects, randomly sampled from the population at large, and (perhaps at a later date) on those
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subjects who experience an event. The sub-cohort in a given stratum constitutes the comparison
set of cases occurring at a range of failure times (Prentice, 1986).
Since detailed procedures for haplotype analysis for case-cohort data have not been seen in
literature, I provide some details on estimating the parameters under the case-cohort setting for
the haplotype-disease risk model (9). For a case-cohort design, the data for individuals in R+
(including case set R1 and controls in the sub-cohort) are Di = (ti, δi,Mi, Zi). However, the
haplotype Hi may not be known for all individuals in R
+. Let S(Mi) be the set of haplotype
pairs consistent with genotype Mi. For individuals in R
− (those in the cohort but not in R+),
we only observe Di = (ti, δi), and for these individuals, let S(Mi) be the set of all possible
haplotypes. Denote D = {D1, · · · , DN} as the observed data, N is the number of individuals in
the full cohort.
Let f(Z) be the marginal distribution of the covariates Z in the population, and G(t) =























where pil, pim are the haplotype frequencies of the haplotypes hl and hm, Hi(l,m) represents the
two haplotypes hl and hm for the ith individual, and θ = {Λ0(t), f(Z), pil, pim, β}. Note that here
we assume that the Hardy-Weinberg equilibrium holds for the haplotypes, although this can be
relaxed by introducing additional parameters. Instead of assuming a particular distribution of
the covariates, we propose to deal with the distribution of Z nonparametrically as in Wellner
and Zhan (1997) and Scheike and Juul (2004).
Since there are two nonparametric terms in this likelihood function, it is difficult to maximize
it directly. We can develop an EM-algorithm instead. To write down the full data likelihood, we
define Wj as the observed jth distinct combinations among the set {Zi : i ∈ R+} for j ∈ j =
1, · · · , J , and the corresponding point mass as p1, · · · , pJ such that
∑
j pj = 1. Then the missing
data are the phases of the haplotypes for some individuals in R+ and both the haplotypes and
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δi(log λ0(ti) + β
′F(Zi, Hi))− Λ0(ti)eβ




















I(Hi = (hl, hm)) log(pilpim). (11)
E-Step: To implement the EM algorithm, we need to obtain the expectation of the equation
(11), which requires the following expectations. First, for an individual i ∈ R+, (Mi, Zi) are
known, but Hi may not be known,






and with this probability, E(F(Zi, Hi)) and E(exp(F(Zi, Hi))) can be derived. For an individual
i ∈ R−, we only observe (ti, δi = 0),











with this probability, E(F(Zi, Hi) and E(exp(F(Zi, Hi))) can be derived.























E[Hj = (hl, hm)|D]eβ
′F(Wj′ ,Hj(l,m))
where Y (ti) is the set of individuals who were at risk at time ti. Finally, the estimator of β is































This is the score equation corresponding to a Cox model with an individual-specific offset term,
which can be easily solved by using the Newton-Ralphson iteration.
Based on different ways of parameterizing the haplotype effects, the test of haplotype effects
can be in general formulated as testing H0 : β1 = 0, where β1 is a sub-vector of β = {β1, β2}.
Similar to Lin (2004) and Scheike and Juul (2004), the likelihood ratio test can be applied for
this null hypothesis.
7 Survival Analysis Methods for Gene Characterization
After the genetic variants related to the risk of disease are identified, it is important to esti-
mate the penetrance of the variants and other population based parameters such as the allele
frequencies. Cohort or case-control family designs can be used for gene characterization and for
estimating population parameters such as genotype relative risk and age-dependent penetrance
functions. For rare diseases, often a large cohort is required for estimating such population pa-
rameters. For case-control family designs, if the genotypes of the disease variants are available
for all the family members, the methods by Li et al. (1998) and Shih and Chatterjee (2002) can
be used for estimating the age-dependent penetrance functions.
When genotypes of the family members are not available, the kin-cohort design (Wacholder
et al., 1998) is a promising alternative to traditional cohort or case-control family designs for
estimating penetrance of an identified rare autosomal mutation. In such a design, a suitably
selected sample of participants provides genotype and detailed family history information on the
disease of interest; however, the genotypes of the family members are not known. Gail et al.
(1999) used the term ”genotyped probands” to emphasize that the probands are genotyped in
kin-cohort design. To estimate penetrance of the mutation, Chatterjee and Wacholder (2001)
considered a marginal likelihood approach that is computationally simple to implement, more
flexible than the original analytic approach proposed by Wacholder et al. (1998) and more robust
than the likelihood approach considered by Gail et al. (1999) to the presence of residual familial
correlation. Chatterjee et al. (2005) further extended the approach of Shih and Chatterjee
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(2002) for data from the kin-cohort design with both cases and control probands and the kin-
cohort design with only cases in order to account for residual correlations. In order to allow for
residual familial aggregation given genotypes, Chatterjee et al. (2005) consider a copula models
(Genest and MacKay, 1986) for specifying joint risks of the disease among the proband and
his/her family members. The key of these various approaches is to make inference based on the
likelihood function that corrects for ascertainment.
8 Ascertainment Correction
Different from traditional multivariate survival analysis, one of the most difficult problems in
analyzing family data in genetic studies is that the families for genetic analysis are often not
random samples from the population; rather, they are often ascertained because of one or more
of the family members are affected with the disease of interest. This ascertainment problem
makes statistical inferences for the proposed models in this paper difficult. For the ascertained
family samples, estimating the population baseline hazard function becomes even more difficult.
One way to go around this problem is by using a retrospective likelihood, which is defined as the
probability of marker data given the observed age of onset data. In order to maximize such a
likelihood function, the baseline hazard function is often assumed to be known or to follow some
parametric form. Due to conditioning, one may expect loss of efficiency in parameter estimates.
Sun and Li (2004) recently proposed and evaluated two approaches based on conditional prospec-
tive likelihood and conditional ascertainment corrected likelihood for the additive genetic gamma
frailty model in order to estimate the baseline hazard function based on the family data collected
for linkage analysis. However, such an ascertainment correction procedure requires knowledge of




9 Survival Analysis Methods in the Genomics Era
Recent development of new high-throughput technologies for generating very high-dimensional
genomic data such as microarray gene expression data raises other important and interesting
problems that require development of new survival analysis methods. One such area is to link
the microarray gene expression data to censored survival outcomes such as cancer recurrence.
Due to high-dimensionality of the data, traditional survival analysis methods cannot be applied
directly to such data sets or are expected to perform poorly.
Currently, there are several classes of approaches for these type of censored data regres-
sion problems in the high-dimension and low sample-size settings. One class of approaches is
dimension-reduction-based methods, such as extensions of the partial least square regression
method for censored data regression problems (Park et al., 2001; Li and Gui, 2004), extension
of the slice inverse regression method (Li and Li, 2004) and supervised principal components
analysis (Bair and Tibshirani, 2004). While these methods may perform well in prediction, they
usually do not provide a direct way of selecting genes that are potentially related to time-to-event.
Another class of approaches is based on regularized estimation procedures such as L2 penalized
estimation (Li and Luan, 2004), the extension of the least absolute shrinkage and selection
operator (Lasso) of Tibshirani (1996) to censored survival data using the least angle regression
(LARS) (Efron et al., 2004; Gui and Li, 2005; Segal, 2006), and the threshold gradient descent
procedure (Friedman and Popescu, 2004; Gui and Li, 2005). These methods provide a way of
selecting genes whose expression might be related to clinical outcome such as time-to-event. In
addition, these methods can also be used for building a model for predicting future patients’
time-to-event.
Survival ensembles, based on extensions of the random forests (Breiman, 2001) and the
gradient descent boosting procedure (Friedman, 2001) to censored survival data, have also been
developed recently (Li and Luan, 2005; Hothorn et al., 2006). These procedures are more flexible
and usually perform better in predicting future patients’ time-to-event.
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10 Conclusion and Future Directions
Since many complex diseases show large variation in age at disease onset, consideration of vari-
able age of disease onset is an important aspect of genetic analysis of complex diseases. Methods
in survival analysis provide a natural framework for incorporating age of onset and environmental
risk factors into genetic analysis. In this paper, I have reviewed some recently developed survival
analysis methods for aggregation, segregation, linkage and association analysis and gene charac-
terization analysis in genetic epidemiology. Most of these methods were developed in the last ten
years and have been shown to be able to offer additional insights into genetic studies of complex
diseases. As user-friendly software packages implementing these methods become available, we
should expect to see more applications of these methods in mapping genes for complex diseases.
With the completion of the Human Genome Project and the HapMap project, genome-wide
association studies of complex traits are now possible and have already been proposed for several
complex diseases. Under such studies, hundreds of thousands of SNPs are typed for a large set of
patients and controls. In addition, large-scale cohort studies are under discussion or are already
underway in the UK (UK Biobank), Iceland (Decode), Germany, Canada and Japan. The US is
also considering to propose its own large-scale population cohort (Collins, 2004). We therefore
expect that large amounts of data will be generated from these large cohort studies in the near
future. Besides large cohort data, case-cohort and nested case-control designs offer alternatives
to cohort and case-control designs. An important research question is how to identify SNPs,
SNP-SNP interactions, gene-gene interaction, gene-environment interactions among hundreds of
thousands of SNPs that may affect the disease risk based on case-cohort or nested case control
data in the framework of survival analysis. In addition, many common diseases are known to be
affected by certain genotype combinations; therefore, statistical methods to detect the influential
genes along with their interaction structures are also required. Finally, new statistical methods
are also required in order to fully utilize the genome-wide linkage disequilibrium patterns and
the haplotype block structures available from the HapMap project. New ideas from statistical
learning (Hastie et al., 2001) hold great promise to address these important issues.
Since genes and proteins almost never work alone, they interact with each other and with
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other molecules in highly structured but incredibly complex ways. Understanding this interplay
of human genome and environmental influences is crucial to developing a systems understanding
of human health and disease. An important venue for future research is to develop methods that
can incorporate known biological knowledge such as pathways into statistical modeling in order
to limit the search space for gene-gene and gene-environment interactions (Conti et al., 2003; Wei
and Li, 2006). Wei and Li (2006) proposed a non-parametric pathways-based regression model to
incorporate pathways information into regression analysis. As biological knowledge accumulates,
one should expect to see development of new methods and more applications of these models in
identifying genes and environmental risk factors that are related to risk of developing disease.
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